0.640
0.00 (-0.28%)
AIStockmoo Score
| Value 30% | 0.0 |
| Low debt. Weak profitability. Ample short-term liquidity. info | |
| From our AI Insight report's view of expected return against risk. info | NA |
| Relative Valuation info | NA |
| Implied Growth info | NA |
| Valuation History info | NA |
| Return on Capital info | NA |
| Earnings Trend info | NA |
| Holdings' Value info | NA |
| Risk Premium info | NA |
| Market Valuation info | NA |
| Timing 30% | -4.5 |
| Downtrend over the past year. Far below its 52-week high. info | |
| In a downtrend: the price is below its moving averages, and they are falling. It has dropped well below them. Volume is heavier on down days. info | |
| From our AI technical analysis of the chart. info | NA |
| Candle Patterns info | NA |
| Sentiment 20% | 0.0 |
| No recent price targets, so based on how targets have been revised. info | |
| Holdings' Sentiment info | NA |
| News Mood info | NA |
| Smart Money 20% | -0.7 |
| Institutions net +0.66% of shares in their latest 13F filings: 10 holders increased, 4 decreased (quarter to 30 Sep 2026). info | |
| Short interest +113.5% from 31 Aug to 30 Oct 2026, 1 days to cover (FINRA). info | |
| Insider Activity info | NA |
| Market and sector conditions are poor. | |
| Market environment cautious. info | |
| Sector lagging the market. | |
| The pillars agree, so the score is strengthened. | |
| Not in score | |
| Below its medium-term trend line. info | |
| Price is low against its 52-week average. Down over 5 years. info | |
| Trend down on all three terms. Short-term momentum falling. info | |
| Levels trending up. info | |
| Final Score | -2.09 |
Market Trend
| Short Term | Medium Term | ||
| Industry | Pharmaceutical Retailers (US) | Mixed | Mixed |
| Pharmaceutical Retailers (Global) | Mixed | Mixed | |
| Stock | DataMeds AI, Inc. | Mixed | Mixed |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B | Score |
|---|---|---|---|---|---|
| MEDS | - | - | - | - | -2.1 |
| WBA | 10 B | 4.34% | - | 1.44 | -2.0 |
| PETS | 19 M | - | - | 1.18 | -3.9 |
| RDGT | 853 K | - | - | 0.020 | -2.2 |
| SCNX | - | - | - | 0.080 | -1.6 |
| HITI | 199 M | - | - | 2.95 | -1.7 |
Select this tab to load the latest available analysis.
|
Trxade Health Inc is a health service IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey, and patient engagement in the U.S. Its products and services include Integra Pharma Solutions, LLC, Community Specialty Pharmacy, LLC, Delivmeds.com, Bonum Health Hub and Application, and others. its business is classified into reportable segments which are Trxade, Inc, Superlatus, LLC, Integra Pharma, LLC, and Other, and the majority of the revenue comes from Trxade, Inc. |
|
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| Investment Style | Small Value |
| % Held by Insiders | 63.99% |
| % Held by Institutions | 10.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Onedigital Investment Advisors Llc | 30 Sep 2026 | 21,369 |
No data within this time range.
No data within this time range.
Institutions
Institutional ownership: 1.62%
| Positions | Holders | Shares |
|---|---|---|
| Increased | 10 | 49,514 |
| Decreased | 4 | 23,584 |
| New | 7 | 34,444 |
| Sold out | 1 | 20,532 |
SEC 13F filings via Nasdaq, latest filings up to 30 Sep 2026. Filings arrive up to 45 days after each quarter.
Short Interest
| Settlement | Shares | Days to cover |
|---|---|---|
| 30 Oct 2026 | 371,417 | 1.0 |
| 15 Oct 2026 | 476,294 | 1.0 |
| 30 Sep 2026 | 525,081 | 1.0 |
| 15 Sep 2026 | 430,628 | 1.0 |
| 31 Aug 2026 | 173,986 | 1.0 |
| 14 Aug 2026 | 164,850 | 1.0 |
FINRA short interest via Nasdaq, reported twice a month.
| Date | Type | Details |
|---|---|---|
| 05 Nov 2026 | Yahoo Finance |
DataMeds AI Signs Preliminary Agreement With Florida Health Insurer for GLP-1 Patient Management App
DataMeds AI, Inc. (NASDAQ:MEDS) announced that it has entered into a non-binding memorandum of understanding (MOU) with a Florida-based health maintenance organization (HMO) to introduce its Health Lives Here mobile application to the insurer’s members, initially focusing on patients receiving… |
| 02 Nov 2026 | Yahoo Finance |
DataMEDS AI Secures Supply Agreement for Six Compounded Peptides Following FDA Advisory Committee Recommendations
DataMEDS AI, Inc. (NASDAQ:MEDS) has announced that its pharmacy subsidiary, Corexa Health, has entered into a commercial supply agreement covering bulk drug substances and active pharmaceutical ingredients (APIs) for six peptides, as the company prepares to expand its compounded prescription… |
| 23 Oct 2026 | Yahoo Finance |
DataMEDS AI Establishes "Health Lives Here" Community Respiratory Program for Corexa Health Pharmacy Network
The aim of HLH CRP is to bring respiratory season best practices to community pharmacies and improve access to protein-based vaccines, diagnostics and therapeutics targeting respiratory infectious diseases as cold and flu season begins across the U. Corexa Pharmacy in Lakeland, Florida will be the… |
| 20 Oct 2026 | Yahoo Finance |
DataMeds Regains Compliance With NASDAQ Listing Standards
TAMPA, FL / ACCESS Newswire / October 20, 2026 / DataMeds AI, Inc. In order to regain compliance with the Equity Rule, DataMEDS needed to have a minimum stockholders' equity of $2… |
| 16 Oct 2026 | Yahoo Finance |
DataMeds AI Plans Peptide Compounding Expansion Through Corexa Health Following FDA Policy Proposal
DataMeds AI, Inc. (NASDAQ:MEDS) has outlined plans to expand into the peptide compounding market through its pharmacy subsidiary, Corexa Health, following a proposed policy change by the U. |
| 16 Oct 2026 | Yahoo Finance |
DataMeds Applauds FDA's Proposed Interim Access Policy for Compounding Using Certain Peptides and Provides Corexa Health's Peptides Roadmap
Corexa Health's three divisions - pharmacy, distribution, and tech & hub - positioned to serve the emerging compounded peptide marketTAMPA, FL / ACCESS Newswire / October 16, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company… |
| 14 Oct 2026 | Yahoo Finance |
DataMEDS Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform
Platform to be integrated into Health Lives Here app as a subscription offeringTAMPA, FL / ACCESS Newswire / October 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS SI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure… |
| 13 Oct 2026 | Yahoo Finance |
DataMEDS SI Provides Business Update On CLIA Lab Helomics And Its Super Intelligence Predictive Oncology Division
Leading Health IT Company has Implemented Cost Control Measures and Refocused Remaining Workforce Towards ChemoFx Commercialization with Hospital Systems, HMOs, GPOs and Cancer Centers TAMPA, FL – DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS SI,” “DataMEDS,” or the “Company”), a… |
| 13 Oct 2026 | Yahoo Finance |
DataMeds AI Announces Workforce Reductions as It Prioritises ChemoFx Cancer Diagnostic Test Commercialisation
DataMeds AI, Inc. (NASDAQ:MEDS) has announced cost-reduction measures, including cuts to corporate management positions, as the company redirects resources towards commercialising its ChemoFx diagnostic laboratory test for gynaecological cancers. |
| 12 Oct 2026 | Yahoo Finance |
DataMeds AI Secures Medicaid Coverage for ChemoFx Assay in Gynecologic Cancers
DataMeds AI’s Helomics subsidiary has received a Medicaid coverage determination under Humana’s policy, potentially expanding reimbursement access for its precision oncology test while supporting commercial growth. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) has secured a Medicaid coverage… |
| 12 Oct 2026 | Yahoo Finance |
DataMEDS SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx(R) Assay In Gynecologic Cancers
Humana adds ChemoFx® to its Medicaid Pharmacogenomics Testing coverage policyTAMPA, FL / ACCESS Newswire / October 12, 2026 / DataMeds AI, Inc. Medical Coverage Policies were reviewed by Humana's Medicaid Coverage Policy Adoption (MCPA) Forum, which incorporated the ChemoFx Assay in its Coverage… |
| 01 Oct 2026 | Yahoo Finance |
DataMeds AI Corexa Pharmacy Surpasses $1 Million in Monthly Revenue as Sales Rise 66%
Corexa Pharmacy’s preliminary September revenue increased more than 66% from July, supported by retail customer growth and the launch of Tollo Health products. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) said Corexa Pharmacy generated preliminary, unaudited September 2026 revenue of more than… |
| 01 Oct 2026 | Yahoo Finance |
DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue
September 2026 revenue up more than 66 percent from July 2026 with expansion of retail customer base and Tollo Health pharmaceutical-adjunct product launchesTAMPA, FL / ACCESS Newswire / October 1, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare… |
| 28 Sep 2026 | Yahoo Finance |
Axe Compute Just Sold Its Cancer Business to Become an AI Stock
Axe Compute stock has rallied over 650% in the past six months as investors increasingly value it as an AI infrastructure stock. The challenge is now delivering on that promise. |
| 28 Sep 2026 | Yahoo Finance |
DataMeds AI Launches Health Lives Here App Focused on GLP-1 Telehealth and Pharmacy Services
DataMeds AI (NASDAQ:MEDS) and Tollo Health launched the Health Lives Here mobile application, combining GLP-1 telehealth, pharmacy services, nutritional products and health tracking as part of a planned broader healthcare network. Key Investor TakeawaysDataMeds AI (NASDAQ:MEDS) and Tollo Health… |
| 28 Sep 2026 | Yahoo Finance |
DataMeds AI stock rises on health app launch
Investing.com -- DataMeds AI Inc (NASDAQ:MEDS) shares jumped 25% Monday following the launch of its Health Lives Here mobile application in partnership with Tollo Health. |
| 28 Sep 2026 | Yahoo Finance |
DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application
Healthcare IT Company and Nutritional Products Maker to Work with NFL Alumni Health to Drive Awareness of GLP-1 Telehealth and Pharmacy ServicesTAMPA, FL / ACCESS Newswire / September 28, 2026 / DataMeds AI, Inc. The companies intend to expand the target patient populations in the fourth quarter of… |
| 25 Sep 2026 | Yahoo Finance |
DataMEDS AI To Present At 2026 National Telehealth and Virtual Care Summit
Interim Co-CEO to Discuss Growing Patient Desire to Own Health DataTAMPA, FL / ACCESS Newswire / September 25, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) ("DataMeds AI," "DataMEDS," or the "Company"), a healthcare company leveraging its Health IT and physical infrastructure together with its artificial… |
| Show more | ||
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 19 Jul 2024 | 08 Jul 2024 | 24 Jul 2024 | 1.5 Cash |
| 25 Mar 2024 | 28 Feb 2024 | 22 Mar 2024 | 8 Cash |
Technical Setup Medium
AI Technical Analysis
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |